New York, Jun 28, 2001 (123Jump via COMTEX) -- Already rallying on stronger-than-expected unemployment data this morning, some techs got a further boost from a favorable Appeals Court ruling in the Microsoft (MSFT) antitrust case. The Nasdaq Composite Index rallied 65.91, or 3.2%, to 2140.65. The big-cap Nasdaq-100 Index jumped 74.93, or 4.3%, to 1830.95. At noon, market internals on the Nasdaq showed the number of advancing issues leading decliners 5 to 3 and up-volume accounting for roughly 85% of trading. Among the most-actively traded issues today: Networking leader Cisco Systems (CSCO) rose 1.02, or nearly 6%, to 18.95. No. 2 software maker Oracle (ORCL) climbed 92 cents, or 5%, to 18.96. Leading chipmaker Intel (INTC) added 1.34, or nearly 5%, to 29.99. Software titan Microsoft gained 1.36, or 2%, to 72.50, before the stock was halted pending the news from Washington. The Appeals Court ruling vacated the lower court's decision to break up the company and sent the case to another lower court judge for a new remedy. The court was particularly hard on Judge Penfield Jackson, who had presided over the case, noting the inappropriateness of his public interviews following the trial. Today's news reopens the possibility of a settlement and will likely bode well for the stock when it continues to trade. A notable loser after the ruling were shares of AOL Time Warner (AOL), down 58 cents, or 1%, to 52.10, and RealNetworks (RNWK), off 34 cents, or 3%, to 11.41. The companies are notable competitors of Microsoft in the dot-com arena. Other software stocks rising today include: Oracle (ORCL), Siebel Systems (SEBL), Adobe Systems (ADBE) and PeopleSoft (PSFT). Multimedia-software maker Macromedia (MACR) was a conspicuous loser, down 1.77, or more than 9%, to 16.95, after the company warned of a first-quarter loss of 15 cents to 20 cents per share excluding items, well below the 13-cent per-share profit expected by Wall Street. . Meanwhile, in the networking space, Corning (GLW) and Corvis (CORV) led the advancers, up 1.40 to 16.05 and 30 cents to 3.90respectively.
Communications chips were especially strong, with doubled-digit percentage gains posted by Vitesse Semiconductor (VTSS), PMC Sierra (PMCS) and TranSwitch (TXCC
J.P. Morgan started coverage of Thoratec Labs (THOR with a "buy" rating and a $17 12-month price target. The analyst also placed the stock on the Small Cap Trading recommended list. Shares blossomed 1.66, or 14.64%, to 13.
Among yesterday’s movers, Cytogen Corp. (CYTO gave back 13 cents to 4.87 after a 17% leap.
Tuesday, the company received positive results from a study of its ProstaScint prostate cancer detection radio-labeled antibody. Data showed that ProstaScint made it possible to identify recurrent prostrate cancer "with greater precision" when used in combination with other diagnostic imaging techniques
Antex reported this morning that it has received a patent for a new class of peptides. The company intends to use the peptides to treat the symptoms of serious lung disorders.
gefunden bei www.123jump.com
Communications chips were especially strong, with doubled-digit percentage gains posted by Vitesse Semiconductor (VTSS), PMC Sierra (PMCS) and TranSwitch (TXCC
J.P. Morgan started coverage of Thoratec Labs (THOR with a "buy" rating and a $17 12-month price target. The analyst also placed the stock on the Small Cap Trading recommended list. Shares blossomed 1.66, or 14.64%, to 13.
Among yesterday’s movers, Cytogen Corp. (CYTO gave back 13 cents to 4.87 after a 17% leap.
Tuesday, the company received positive results from a study of its ProstaScint prostate cancer detection radio-labeled antibody. Data showed that ProstaScint made it possible to identify recurrent prostrate cancer "with greater precision" when used in combination with other diagnostic imaging techniques
Antex reported this morning that it has received a patent for a new class of peptides. The company intends to use the peptides to treat the symptoms of serious lung disorders.
gefunden bei www.123jump.com
